Ekaterina Pivovarova to Humans
This is a "connection" page, showing publications Ekaterina Pivovarova has written about Humans.
Connection Strength
0.439
-
Pivovarova E, Friedmann PD, Sawicki J, Bratberg J. Pharmacist roles enhancing substance use disorder treatment access, continuation, and education in a problem-solving court. J Am Pharm Assoc (2003). 2025 Nov-Dec; 65(6):102481.
Score: 0.036
-
Pivovarova E, Taxman FS, Boland AK, Andraka-Christou B, De La Cruz BA, Smelson D, Lemon SC, Friedmann PD. Medication for Opioid Use Disorders (MOUD) Providers' Experiences with Recovery Courts: Qualitative Study of Individual and Systemic Factors Impacting Interagency Collaboration. Subst Use Addctn J. 2025 Jul; 46(3):531-540.
Score: 0.035
-
Pivovarova E, Planas Garcia BY, Friedmann PD, Stopka TJ, Santelices C, Evans EA. Collaborating With Jails to Provide Community-based Medication for Opioid Use Disorder: Qualitative Perspectives From MOUD Treatment Providers. J Addict Med. 2025 Jan-Feb 01; 19(1):95-101.
Score: 0.035
-
Andraka-Christou B, Viglione J, Ahmed F, Del Pozo B, Atkins DN, Clark MH, Totaram R, Pivovarova E. Factors affecting problem-solving court team decisions about medications for opioid use disorder. J Subst Use Addict Treat. 2025 Jan; 168:209525.
Score: 0.034
-
Pivovarova E, Taxman FS, Boland AK, Smelson DA, Lemon SC, Friedmann PD. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers. J Subst Use Addict Treat. 2023 04; 147:208950.
Score: 0.030
-
Pivovarova E, Evans EA, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug Alcohol Depend. 2022 05 01; 234:109394.
Score: 0.029
-
Christopher PP, Pridgen BE, Pivovarova E. Experiences of Court Clinicians Who Perform Civil Commitment Evaluations for Substance Use Disorders. J Am Acad Psychiatry Law. 2021 Jun; 49(2):187-193.
Score: 0.027
-
Grossi LM, Green D, Cabeldue M, Pivovarova E. Assessing feigning with the Feigning Evaluation INtegrating Sources (FEINS) in a forensic psychiatric sample. Psychol Serv. 2022 May; 19(2):213-224.
Score: 0.026
-
Pivovarova E, Min HS, Friedmann PD. Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders. Subst Abus. 2021; 42(4):618-624.
Score: 0.026
-
Pivovarova E, Klitzman RL, Murray A, Stiles DF, Appelbaum PS, Lidz CW. How Single Institutional Review Boards Manage Their Own Conflicts of Interest: Findings From a National Interview Study. Acad Med. 2019 10; 94(10):1554-1560.
Score: 0.024
-
Pivovarova E, Stein MD. In their own words: language preferences of individuals who use heroin. Addiction. 2019 10; 114(10):1785-1790.
Score: 0.024
-
Pivovarova E, Tanaka G, Tang M, Bursztajn HJ, First MB. Is Helplessness Still Helpful in Diagnosing Posttraumatic Stress Disorder? J Nerv Ment Dis. 2016 Jan; 204(1):3-8.
Score: 0.019
-
Lidz CW, Albert K, Appelbaum P, Dunn LB, Overton E, Pivovarova E. Why is therapeutic misconception so prevalent? Camb Q Healthc Ethics. 2015 Apr; 24(2):231-41.
Score: 0.018
-
Friedmann PD, Wilson D, Stopka TJ, Bernson D, Pivovarova E, Ferguson W, Hoskinson RA, Rottapel RE, Bovell-Ammon B, Gaba A, Morgan JR, Senst T, Hayes E, Evans EA. Medications for Opioid Use Disorder in County Jails - Outcomes after Release. N Engl J Med. 2025 Sep 11; 393(10):994-1003.
Score: 0.009
-
Stopka TJ, Rottapel R, Friedmann PD, Pivovarova E, Evans EA. Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study. Addict Sci Clin Pract. 2024 Sep 12; 19(1):68.
Score: 0.009
-
Evans EA, Pivovarova E, Senthilkumar R, Rottapel RE, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Int J Drug Policy. 2023 12; 122:104252.
Score: 0.008
-
Matsumoto A, Santelices C, Evans EA, Pivovarova E, Stopka TJ, Ferguson WJ, Friedmann PD. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. Int J Drug Policy. 2022 11; 109:103823.
Score: 0.007
-
Stopka TJ, Rottapel RE, Ferguson WJ, Pivovarova E, Toro-Mejias LD, Friedmann PD, Evans EA. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. Int J Drug Policy. 2022 Dec; 110:103803.
Score: 0.007
-
Evans EA, Pivovarova E, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. J Subst Abuse Treat. 2022 07; 138:108746.
Score: 0.007
-
Evans EA, Stopka TJ, Pivovarova E, Murphy SM, Taxman FS, Ferguson WJ, Bernson D, Santelices C, McCollister KE, Hoskinson R, Lincoln T, Friedmann PD. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN). J Subst Abuse Treat. 2021 09; 128:108275.
Score: 0.007
-
Murray A, Pivovarova E, Klitzman R, Stiles DF, Appelbaum P, Lidz CW. Reducing the Single IRB Burden: Streamlining Electronic IRB Systems. AJOB Empir Bioeth. 2021 Jan-Mar; 12(1):33-40.
Score: 0.006
-
Klitzman R, Appelbaum PS, Murray A, Pivovarova E, Stiles DF, Lidz CW. When IRBs Say No to Participating in Research about Single IRBs. Ethics Hum Res. 2020 Jan; 42(1):36-40.
Score: 0.006
-
Klitzman R, Pivovarova E, Murray A, Appelbaum PS, Stiles DF, Lidz CW. Local Knowledge and Single IRBs for Multisite Studies: Challenges and Solutions. Ethics Hum Res. 2019 Jan; 41(1):22-31.
Score: 0.006
-
Lidz CW, Pivovarova E, Appelbaum P, Stiles DF, Murray A, Klitzman RL. Reliance agreements and single IRB review of multisite research: Concerns of IRB members and staff. AJOB Empir Bioeth. 2018 Jul-Sep; 9(3):164-172.
Score: 0.006